Skip to content

SYNERGY™ H7493926020500Recalls & reported problems

Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant

All models of SYNERGY (74)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729973447), received between May 21, 2019 and Dec 9, 2024 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Device-Device Incompatibility1
  • Difficult to Advance1
  • Difficult to Remove1
  • Failure to Deflate1
  • Material Deformation1
  • Migration1

Patient problems

  • No Consequences Or Impact To Patient3
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 9, 2024Migration; Failure to Deflate; Migration; Failure to Deflate

    IT WAS REPORTED THAT DEFLATION ISSUES OCCURRED. UPON DEPLOYMENT OF A 5.0 X 20 SYNERGY DRUG-ELUTING STENT AT THE PROXIMAL SEGMENT OF THE RIGHT RENAL ARTERY, IT WAS OBSERVED THAT THE STENT BALLOON DID NOT FULLY DEFLATE, ONLY THE PROXIMAL PART DEFLATED. THE DELIVERY SYSTEM WAS REMOVED BUT THIS PARTIAL DEFLATION RESULTED IN A SEGMENT OF THE STENT BEING INADVERTENTLY PULLED INTO THE AORTA. THE PROCEDURE WAS SUCCESSFULLY COMPLETED USING AN ALTERNATIVE DEVICE, AND NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20880858 ↗
  • MalfunctionDec 3, 2020Break; Difficult to Advance; Break; Difficult to Advance

    IT WAS REPORTED THAT A SHAFT FRACTURE OCCURRED. THE TARGET LESION WAS LOCATED IN A CALCIFIED ARTERY. A 5.00 X 20 SYNERGY II DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, THE DEVICE GOT STUCK AND FRACTURED. THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED AND THE PATIENT'S STATUS WAS STABLE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10938127 ↗
  • MalfunctionNov 18, 2019Difficult to Remove; Difficult to Remove

    IT WAS REPORTED THAT CATHETER REMOVAL DIFFICULTIES WERE ENCOUNTERED. A 5.00X20MM SYNERGY II DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, IT WAS NOTED THAT THE STENT DELIVERY SYSTEM WOULD NOT DRAW BACK INTO THE GUIDE CATHETER. NO PATIENT COMPLICATIONS WERE REPORTED. IT WAS FURTHER REPORTED THAT AFTER THE CATHETER WAS STUCK POST STENT DEPLOYMENT, THE DEVICE WAS PULLED NEGATIVE TWICE ON THE INFLATION DEVICE AND IT WAS ABLE TO RETURN BACK INTO THE GUIDE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9335673 ↗
  • MalfunctionMay 21, 2019Device-Device Incompatibility; Material Deformation; Device-Device Incompatibility; Material Deformation

    IT WAS REPORTED THAT STENT BECAME DAMAGED DURING WITHDRAWAL THROUGH THE GUIDE EXTENSION CATHETER. A 6FR GUIDEZILLA II AND A 5X20 SYNERGY STENT WERE SELECTED FOR USE FOR A CORONARY INTERVENTION PROCEDURE IN THE RIGHT CORONARY ARTERY. DURING THE PROCEDURE, A LOT OF RESISTANCE WAS FELT ADVANCING THE STENT THROUGH THE GUIDEZILLA. THE PHYSICIAN ATTEMPTED TO PULL THE STENT OUT OF THE GUIDEZILLA, BUT THE STENT STRUTS BECAME DAMAGED. THE STENT REMAINED ON THE DELIVERY BALLOON, HOWEVER, THE BALLOON WAS STICK IN THE GUIDEZILLA. THE PHYSICIAN THEN REMOVED EVERYTHING FROM THE PATIENT. THE PHYSICIAN THOUGHT THAT THE 5X20 SYNERGY WAS TOO LARGE TO FIT THROUGH THE GUIDEZILLA. THE PROCEDURE WAS COMPLETED BY USING A NEW GUIDEZILLA AND A SMALLER STENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT WAS FINE POST PROCEDURE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8627473 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page